🎯 check SB203580 (Adezmapimod) product page
SB203580 (Adezmapimod) is a highly selective p38 MAPK inhibitor. It affects p38 MAPK and NF-κB signaling pathways by blocking p38 phosphorylation and downstream targets, thereby inhibiting inflammation, oxidative stress, apoptosis, and fibrosis.